Prophylactic Modified McCall Culdoplasty During Total Laparoscopic Hysterectomy

Sponsor
University of North Carolina, Chapel Hill (Other)
Overall Status
Completed
CT.gov ID
NCT01840176
Collaborator
(none)
50
1
2
19
2.6

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the feasibility of performing prophylactic McCall culdoplasty at the time of total laparoscopic hysterectomy. The investigators will also be measuring pelvic support (using POP-Q) and sexual function before and at different time points (up to 12 months) postoperatively.

The investigators hypothesize that women undergoing the McCall culdoplasty will not have different immediate surgical outcomes (operative time, etc) and may have better pelvic support and sexual function in the future.

Condition or Disease Intervention/Treatment Phase
  • Procedure: McCall culdoplasty
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Prophylactic Modified McCall Culdoplasty During Total Laparoscopic Hysterectomy
Actual Study Start Date :
May 1, 2013
Actual Primary Completion Date :
Jun 1, 2014
Actual Study Completion Date :
Dec 1, 2014

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Routine

These women are randomized to receive no McCall culdoplasty at the time of their total laparoscopic hysterectomy.

Other: McCall culdoplasty

The women in this arm are those randomized to undergo a McCall culdoplasty at the time of their total laparoscopic hysterectomy.

Procedure: McCall culdoplasty
The modified McCall Culdoplasty procedure is a relatively simple procedure that is performed after removal of the uterus and cervix from the apex of the vagina wherein the angles of the vagina are attached to their respective uterosacral ligament and the cul-de-sac is surgically obliterated for support postoperatively. This is done with a single 0-vicryl suture. There will be no additional interventions applied during the hysterectomy aside from the McCall culdoplasty.

Outcome Measures

Primary Outcome Measures

  1. Feasibility [6 months]

    The primary aim of the study is to generate feasibility data for performing a powered randomized trial on prophylactic modified McCall's culdoplasty during benign total laparoscopic hysterectomy. As such, we will measure operative time with the hypothesis that the intervention does not add significant additional effort. We will also collect information regarding patient willingness to participate as well as intra- and post-operative complication data.

Secondary Outcome Measures

  1. Pelvic support [12 months]

    This study will also allow us to collect data regarding differences in POP-Q exams up to 12 months after surgery.

  2. Sexual function [12 months]

    We will also collect data regarding sexual function at different time points pre and postoperatively up to 12 months after surgery using the validated Female Sexual Function Index (FSFI) questionnaire.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 99 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women aged 18-99 undergoing elective laparoscopic hysterectomy for benign indications with surgeons in the division of Advanced Laparoscopy and Pelvic Pain at UNC-Chapel Hill.
Exclusion Criteria:
  • Current symptomatic or asymptomatic pelvic organ prolapse as measured by the Pelvic Organ Prolapse Quantification (POPQ) system.

  • Pregnancy

  • Non-English speaking

  • Unable to provide informed consent

  • Pathology causing an obliterated cul-de-sac

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of North Carolina at Chapel Hill Chapel Hill North Carolina United States 27599

Sponsors and Collaborators

  • University of North Carolina, Chapel Hill

Investigators

  • Principal Investigator: Kumari Hobbs, MD, UNC Chapel Hill Dept of OB/GYN
  • Study Director: Matthew Siedhoff, MD, UNC Chapel Hill Dept of OB/GYN

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of North Carolina, Chapel Hill
ClinicalTrials.gov Identifier:
NCT01840176
Other Study ID Numbers:
  • 13-0101
First Posted:
Apr 25, 2013
Last Update Posted:
Apr 18, 2017
Last Verified:
Apr 1, 2017
Keywords provided by University of North Carolina, Chapel Hill
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 18, 2017